First Graphene Limited (ASX:FGR; "First Graphene" or "the Company") is pleased to announce it has entered an exclusive Licence Agreement ("Agreement") with Halocell Australia ("Halocell") to ...
Guardant Health’s consensus analyst price target has recently moved upward from $93.82 to $99.00, signaling increased confidence in the company's future. This upgrade comes amid a surge in positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback